Funding Announcements
Upcoming Deadlines
December 2008
UCCC Funding
Sallie Rosen Kaplan
AACR Fellowship
NIH Pioneer Award
CDPHE Grant
ACSBI Funding
Paul Calabresi
Alex's Lemonade Stand
ASCO
CBSA
January
Read More
Week of Nov. 17
Sallie Rosen Kaplan Fellowship for Women in Basic, Clinical, Epidemiological or Prevention Science
Deadline: Dec. 12
More Information: http://www.training.nih.gov/apps/publicForms/postdoctoral/forms/adIndex.aspx
The Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research is made possible by a generous bequest to the Foundation for NIH (FNIH). This is a competitive program for postdoctoral fellows applying to train in any of the National Cancer Institute's intramural research settings, including basic, clinical, epidemiological, and prevention science.
The postdoctoral fellowship experience at the NCI can serve as a first postdoctoral training assignment. For more experienced postdoctoral scientists, it can offer an opportunity to further their training in more advanced methods, to acquire new research capabilities, to make changes in the direction of their research, or to receive training in fundamental sciences and clinical disciplines for the purpose of enhancing the transfer of biotechnology to cancer clinical programs.
Program duration is normally 2 to 5 years. Fellows will be supported by a Cancer Research Training Award (CRTA), with an augmented stipend in the first year provided by the FNIH. The CRTA Fellowship stipend range is $46,200 to $78,000 commensurate with level of experience. Standard self and family health insurance is provided and high option coverage is available.
Candidates for the Sallie Rosen Kaplan Fellowship must be female, must possess a doctoral degree, and must have less than 5 years postdoctoral research experience. U.S. citizenship or U.S. permanent residency (green card) is required. Finalists for the Kaplan fellowship will be notified by March 2009 and winners announced by May 2009. To be eligible for the Sallie Rosen Kaplan Fellowship award, the starting date of any NCI fellowship must be no earlier than December 15, 2008. Applicants are required to apply online by December 12, 2008.
Questions concerning the Sallie Rosen Kaplan Fellowship may be addressed to Ms. Sandy Koeneman at koenemas@mail.nih.gov or (301) 496-0807.
Leukemia Research Foundation Research Grants Program
Deadline: February 13, 2009
More information
The Leukemia Research Foundation dedicates funds to support research related to leukemia, lymphoma, and myelodysplastic syndromes. The goal of the Hollis Brownstein Research Grants Program is to support new investigators; preference will be given to applicants demonstrating new lines of investigation.
The Leukemia Research Foundation is currently funding New Investigators only. New Investigator research grants are for a period of one year for up to $100,000. Award funds are transferred quarterly to the institutional office of grant administration or sponsored programs. The next funding cycle begins on July 1, 2009.
CTEP LOI for Phase I and Phase II Trials, GDC-0449
Deadline: Jan. 21, 2009, 5 p.m. ET
Attached is the official Letter of Intent (LOI) solicitation for Phase I and Phase II trials, GDC-0449.
The last day to receive your Mass Solicitation LOI is January 21, 2009 at 5 PM (ET). Please be aware of server problems or e-mail issues that may cause your submission to be delayed, and take appropriate measures to ensure that your proposal arrives before the deadline.
Due to the specified request for this particular solicitation and possible high volume of submissions, PIO requires that “GDC-0449 Mass LOI" be included in the subject line when submitting your LOI. Please note the following:
- To help us forecast the volume of submissions, please acknowledge receipt of this e-mail and indicate if you do or do not intend to respond to the solicitation. This information will help us allocate the staff and resources needed to process the LOI in a timely manner.
- Before submitting your LOI, please check carefully for accuracy and completeness. Once you have submitted the LOI, please do not send a revision until after CTEP has completed its initial review. This will greatly reduce abstraction errors and confusion.
- If you plan on submitting more than one LOI, please send each LOI in separate emails.
- LOI submissions after January 21st, 2009, 5 PM (ET) will be accepted but the review may be delayed.
- You will receive a confirmation email from PIO with the LOI reference number within 72 hours.
For your convenience, attached are the current CTEP LOI template (revised 01/04/2008) and the MeDRA disease code listing.
If you have questions or concerns after submitting the LOI, please contact me by e-mail (pio@ctep.nci.nih.gov) or by phone, (301) 496-1367 and please refer to the CTEP LOI number.
Week of Nov. 10
Jane Coffin Childs Memorial Fund for Medical Research Fellowship Awards
Deadline: February 2, 2009
More Information
The Fund awards fellowships to suitably qualified individuals for full time postdoctoral studies in the medical and related sciences bearing on cancer.
The basic stipend at present is $43,000 the first year, $44,000 the second year, and $46,000 the third year, with an additional $1000 for each dependent child. There is no dependency allowance for a spouse.
An allowance of $1,500 a year toward the cost of the research usually will be made available to the laboratory sponsoring the fellow. A travel award will be made to the Fellow and family for travel to the sponsoring laboratory. Return travel for Fellows will be considered depending upon the Fellow’s plans and situation at the time.
Conditions under which these awards are made
Applicants in general should not have more than ONE YEAR of postdoctoral experience. They must hold either the M.D. degree or the Ph.D. degree in the field in which they propose to study, or furnish evidence of equivalent training and experience.
The appointment will normally be for three years. The Fund recognizes that in some instances there may be valid reasons for changing both laboratory and sponsor. Such changes require the permission of the Director with the advice of the Board of Scientific Advisers. Applicants who, at the time of initiation of the fellowship, will have completed one year in a position as postdoctoral fellow or equivalent will usually be awarded a maximum of two years of fellowship support from this foundation. Only under exceptional circumstances will an award be made to an individual who will have had two years or more of postdoctoral research experience.
Applicants may be citizens of any country, but for foreign nationals awards will be made only for study in the United States. American citizens may hold a fellowship either in the United States or in a foreign country.
In addition to submitting evidence as to pre- and post-doctoral training, an applicant must supply:
-
the names and addresses of three individuals personally acquainted both with the applicant and with the applicant’s professional work, one of whom should be the principal predoctoral advisor;
-
a suitably documented outline of the research problem proposed; and
-
the written consent of the chief of laboratory and a responsible fiscal officer of the host institution indicating their willingness to accept and provide necessary facilities for the Fellow.
(Please note that in the event of multiple applications, it is the policy of the Fund to initiate no more than one fellowship under a particular sponsor in any fiscal year.)
American Association for Cancer ResearchPostdoctoral Fellowships
Deadline: December 10, 2008
More Information
AACR Basic Cancer Research Fellowships (joint application for the following Fellowships):
- AACR Anna D. Barker Fellowship in Basic Cancer Research: One-year grant of $40,000. One Fellowship will be awarded this cycle.
- AACR-Astellas USA Foundation Fellowships in Basic Cancer Research: One-year grant of $30,000. Two Fellowships will be awarded this cycle.
AACR Clinical/Translational Research Fellowships(joint application for the following Fellowships):
- AACR-Astellas USA Foundation Fellowship in Clinical/Translational Cancer Research: One-year grant of $30,000. One fellowship will be awarded this cycle.
- AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research: One-year grant of $40,000. One Fellowship will be awarded this cycle.
- AACR-AstraZeneca Fellowship for Translational Lung Cancer Research: Two-year grant of $90,000. One Fellowship will be awarded this cycle.
Week of Nov. 3
NIH Director's Pioneer Award
Pre-application Deadline: Dec. 17
More Information
Part of the NIH Roadmap for Medical Research, the NIH Director's Pioneer Award will support exceptionally creative scientists who propose highly innovative—and often unconventional—approaches to major challenges in biomedical or behavioral research. Women and members of groups that are underrespresented in NIH research areas are especially encouraged to apply.
- $2.5 million in direct costs over 5 years
- 5-10 awards expected each September
Open to scientists who:
- Are at an institution in the United States
- Are at any career stage
- Will commit at least 51% of their research effort to the project
NIH Director's New Innovator Award
Pre-application deadline: Jan. 15
More Information
Part of the NIH Roadmap for Medical Research, the NIH Director's Pioneer Award will support exceptionally creative scientists who propose highly innovative—and often unconventional—approaches to major challenges in biomedical or behavioral research. Women and members of groups that are underrespresented in NIH research areas are especially encouraged to apply.
- $1.5 million in direct costs over 5 years
- Up to 24 awards expected each September
Open to Early Career Investigators who:
- Have not yet obtained an NIH R01 or similar grant
- Hold an independent research position at an institution in the United States
- Received a doctoral degree or completed medical internship and residency within the past 10 years
- Will commit at least 25% of their research effort to the project
Cancer, Cardiovascular Disease and Pulmonary Disease Competitive Grants Program for Fiscal Year 2009-2010
The 2009/2010 Request for Applications for the Cancer, Cardiovascular Disease and Pulmonary Disease Competitive Grants Program is now available at http://www.cdphe.state.co.us/pp/ccpd/index.html There will be an Applicants’ Conference on November 20, 2008 from 10:00 to 11:30 a.m. at the American Cancer Society, 2255 South Oneida Street , Denver, CO in the Brooks Conference Center . Questions related to this RFA will be addressed at that time. Applicants unable to attend the Conference in person may join the meeting via teleconference. Answers to questions posed during this meeting will be posted on the program website at www.cdphe.state.co.us/pp/ccpd on December 1, 2008. Participation in this meeting is optional. To obtain teleconference and RSVP information, please download the RFA Guidelines at the website listed above.
ASCO Cancer FoundationTranslational Research Professorship
Letter of Intent Deadline: Nov. 20
More Information
The Translational Research Professorship provides funds to translational researchers who have made significant contributions to the direction of cancer research. Furthermore, it is expected that these researchers will continue to provide leadership in their research area. In general, applicants must hold the rank of full professor (or equivalent) at an academic medical center. The award of $100,000 per year for five years can be budgeted at the recipient's discretion.
Colorado Department of Public Health and Environment – Health Disparities Grant Program
Deadline: Dec. 15
More Information
The purpose of this grant program is to provide financial support for statewide initiatives that address prevention, early detection and treatment of cancer; cardiovascular disease, including diabetes and other precursors; and pulmonary diseases in under-represented populations in Colorado. This program is supported with funding from the tobacco tax initiative, allocated through House Bill 05-1262.
The legislation states that grant applications shall address at least one of the following program criteria:
- Translating evidence-based strategies regarding the prevention and early detection of cancer, cardiovascular disease, and chronic pulmonary disease into practical application in healthcare, workplace and community settings.
- Providing appropriate diagnosis and treatment services for anyone who has abnormalities discovered in screening and early detection programs funded through this initiative.
- Implementing education programs for the public and/or healthcare providers regarding the prevention, early detection and treatment of cancer, cardiovascular disease and chronic pulmonary disease.
- Providing evidence-based strategies to overcome health disparities in the prevention and early detection of cancer, cardiovascular disease and chronic pulmonary disease.
Applicants may request a maximum of $200,000 per fiscal year.
Week of Oct. 27
American Cancer Society International Fellowships for Beginning Investigators (ACSBI)
Deadline: Dec. 1
More Information
12 month grant for investigators, clinicians, epidemiologists and public health professionals. $45,000 for travel and stipend.
Objectives
-
To foster a bi-directional flow of research knowledge, experience, expertise, and innovation between countries
-
To advance the academic career development of beginning cancer investigators through clinical, behavioral or basic research projects
Goals
Successful projects should result in increased research capacity; building up of infrastructure capacity at the home institution; cancer control; reduced burden of cancer in own country; development of individuals to disseminate and apply learned skills and knowledge upon return to home institute.
International Association for the Study of Lung Cancer Fellowship Awards
Deadline: Jan. 10
More Information
IASLC Lung Cancer Fellowship Award/Young Investigators Award - 2 years duration
IASLC/PCF Prevent Cancer Foundation Fellowship Award - 2 years duration
IASLC/National Lung Cancer Partnership Fellowship Award - 2 years duration
Overall there are 18 potential awards for two years each. There are awards in prevention and translational lung cancer research that are jointly sponsored with the Prevent Cancer Foundation, (PCF), through educational grants from Eli Lilly. There are unrestricted awards in any field of lung cancer research supported by educational grants from National Lung Cancer Partnership, GlaxoSmithKline, Sanofi-Aventis, AstraZeneca, Celgene, Pfizer, Eli Lilly, and OSI.
This year 6 new unrestricted awards of $40,000 each year for 2 years are available for competition.
Week of Oct. 20
Susan G. Komen for the Cure/ASCO Loan Repayment Program
Deadline: Jan. 15, 2009
More Information
The Komen/ASCO Loan Repayment Program (LRP) provides repayment of qualifying educational loans to oncologists, or to oncology fellows upon completion of training, who commit to practicing clinical oncology full-time for two years in a medically underserved region of the United States. The LRP will repay up to $35,000 per year for two years (up to $70,000 total) of qualifying educational loans.
Application guidelines
Alliance for Cancer Gene Therapy
The Joan Miller and Linda Bernstein Gene Therapy Ovarian Cancer Award
Abstract Deadline: Feb. 6, 2009 4:00 PM EST. Selected applicants will be invited to submit a full proposal due March 19, 2009
More Information
The sponsor funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Gene Therapy for Cancer to qualified scientists at the assistant professor level and above.
This award is specifically for those conducting gene therapy research for ovarian cancer and is titled The Joan Miller and Linda Bernstein Gene Therapy Ovarian Cancer Award.
Week of Oct. 13
UCCC Paul Calabresi Clinical Oncology Scholars Award
Deadline: Dec. 17, 5 p.m.
More Information
The University of Colorado Cancer Center has openings for two additional Calabresi Scholars. The purpose of this program is to prepare highly qualified clinical therapeutic researchers called Paul Calabresi Clinical Oncology Research Scholars (Scholars) who are capable of :
- Communicating and coordinating clinical research activities in teams of clinical and basic/behavioral research scientists to expedite translation of scientific findings into human-oriented research;
- Performing independent clinical research that develops and tests rational hypotheses based on fundamental and clinical research findings in order to improve the medical care of cancer patients or to prevent development of cancer in populations at risk;
- Managing all phases of clinical trials research, including designing and implementing innovative translational clinical protocols.
What the award provides:
- 2-5 years of mentored support
- Up to $75,000 salary plus fringe benefits per annum
- $30,000 per annum research and educational costs
- Structured mentoring and defined training program with a primary mentor in the Scholar’s discipline and two or more additional mentors
- Scheduled formal evaluation of progress and feedback from Advisory Committee
- Further detailed description
Eligible applicants:
- MD, PhD, PharmD junior faculty or senior fellows
- Dedicated to career in clinical translational cancer research
- U.S. citizen, national, or permanent resident
- Completion of clinical training in residency or clinical fellowship or completion of at least two years of postdoctoral training (for basic science candidates)
Alex’s Lemonade Stand Foundation Funding Opportunities
Deadline: December 15, 2008
More Information
Pediatric Oncology Program Infrastructure Awards: These are center-based grants designed to support the infrastructure necessary to administer Phase I and II clinical trials. It is expected that these applications will be submitted by seasoned translational/clinical scientists and will be designed to catalyze early phase clinical trial research efforts .
Unlike traditional granting mechanisms to individuals for individual research efforts, these grants will be made to institutions/organizations that demonstrate outstanding dedication to performing translational research and document a need for clinical research support. These grants will fund the individuals critical to accomplishing the research mission of delivering new drugs to children with cancer such as research nurses, clinical research assistants, data managers, nurse practitioners, or critical equipment. Maximum $125,000 in direct costs will be awarded to applicants annually.
Young Investigator Awards: These grants are designed as start-up funds for new scientists at the end of their fellowship training or early in their research career. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application. Maximum $40,000 in direct costs will be awarded to applicants annually.
Innovation Awards: These grants are designed as seed funding for mid-career researchers with a novel approach to pediatric cancer scientific investigation. Alex’s Lemonade Stand Foundation is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. Alex’s Lemonade Stand will award Innovation Awards of up to $100,000/year for up to two years to support research proposals to be carried out by investigators who are already established, with a track record of peer-reviewed publications and evidence of successfully competing for substantial extramural funding in other areas.
ASCO Cancer Foundation 2009 Advanced Clinical Research Award in Glioma
Letter of Intent: Dec. 4
Application Deadline: Jan. 8, 2009
More Information
The Advanced Clinical Research Award (ACRA) is designed to fund investigators who are committed to clincal cancer research and who wish to conduct original research not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studes (even if clinically relevant) are not allowed.
ASCO Cancer Foundation 2009 Advanced Clinical Research Award in Breast Cancer
Letter of Intent: Dec. 4
Application Deadline: Jan. 8, 2009
More Information
The Advanced Clinical Research Award (ACRA) is designed to fund investigators who are committed to clinical cancer research and who wish to conduct original research not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studes (even if clinically relevant) are not allowed.
Week of Oct. 6
Sidney Kimmel Foundation for Cancer Research
Deadline: December 3, 2008
More Information
Kimmel Scholar Award
To select the grant recipients, the Sidney Kimmel Foundation for Cancer Research has created a Medical Advisory Board consisting of distinguished cancer researchers. Each year the Kimmel Foundation expects to select up to ten grant recipients who will receive $100,000 per year for two years. Qualified applicants must hold an MD, PhD or equivalent graduate degree and must perform research in an American not-for-profit institution during the period of Kimmel Foundation support.
The Kimmel Foundation is seeking accomplished young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2005. However, physicians who have both clinical and research responsibility are eligible if appointed on or after July, 2004. These awards are designed for researchers who do not yet have their own R01 funding. Applicants will be judged on the basis of quality of prior work, research proposed and letters of support. Funding of awards will be subject to execution of binding agreements setting forth terms and conditions under which scholarships will be provided. Applicants for 2009 awards will be notified by mid-April, 2009.
The Kimmel Translational Science Award
The Foundation provides five additional awards specifically for physicians engaged in translational science. Eligibility includes those with MD or equivalent degrees, who have achieved the rank of Assistant Professor on or after July, 2004. Candidates must not hold R01 funding for the laboratory component of their cancer research. Applicants must demonstrate a significant personal involvement in the laboratory component of the translational project described. The translational research may involve primarily animal studies but must include reasonable application to subsequent human investigation.
Association for Research of Childhood Cancer Research Grants
Deadline: January 1, 2009
More Information
The purpose of the Association For Research of Childhood Cancer grant awards is to provide funding for basic science and clinical projects related to the goal of advancing knowledge in Pediatric and Adolescent cancers. All grants are peer reviewed by the Medical/Scientific Advisory Board. Funding decisions are made by the AROCC Board based on the recommendations of the Medical/Scientific Advisory Board and the availability of funds.
The Association for Research of Childhood Cancer does NOT provide funding for travel, photocopying, general office costs and grant or salary overhead costs and fringe benefits. It is the responsibility of the applicant to obtain all appropriate administrative clearances, including if necessary, Institutional Review Board approval. Deadline for application is January 1st for awards in June of the following year. A complete report of research activities including publications and other grants resulting from the work must be submitted within three (3) months of grant ending or termination.
We provide support for multiple, one-year "seed type" grants (not to exceed $30,000) addressing basic science and/or clinical research in areas directly or indirectly related to research issues in Pediatric or Adolescent cancer research. The number of such awards will vary depending on availability of funds in any granting period.
American Association for Cancer Research
Deadline: Nov. 10
More Information
Pancreatic Cancer Action Network-AACR Pilot Grants
The Pancreatic Cancer Action Network-AACR Pilot Grants represent a joint effort to promote and support new ideas and innovative models that have direct application and demonstrate direct relevance to pancreatic cancer. In addition to pancreatic cancer researchers, investigators with experience in other areas of cancer research who have promising and realistic research approaches that can be applied to pancreatic cancer are also invited to apply.
The Grants are for a two-year period and range from $100,000 - $200,000 over the grant term, depending upon project requirements. Grant funds support direct research expenses, which may include the salary and benefit of postdoctoral/clinical research fellows or research assistants.
Pancreatic Cancer Action Network-AACR Career Development Awards
AACR Career Development Awards are open to junior faculty at an academic, medical, or research institution who completed postdoctoral studies or clinical fellowships no more than three years prior to the start of the grant term. The Awards provide two-year grants of $50,000 per year for direct research expenses and salary support.
Pancreatic Cancer Action Network-AACR Fellowship
AACR Postdoctoral Fellowships are open to Postdoctoral Fellows and Clinical Research Fellows who are working at an academic facility, teaching hospital, or research institution and who will be in the first, second, or third year of their postdoctoral training at the start of the fellowship term. Fellowships support the salary and benefits of the Fellow, with partial funds (up to 25% of the total grant) permitted to be designated to direct research expenses. One-year grant of $45,000. U.S. institutions only. One Fellowship will be awarded this cycle.
Pfizer Medical & Academic Partnerships (MAP)
Deadline: Jan. 31
More information
Since 1982, Pfizer has sponsored MAP grants to reflect their deep commitment, as well as what they believe is their responsiblity, to improve health. The funding provided by the MAP grants allows individuals and institutions to pursue cutting-edge research and innovative education.
Pfizer Fellowships: $130,000 payable over 2 years to support talented postdocs in Oncology (and other therapeutic areas).
Pfizer Scholars Grant: Up to 2 grants available, each with $130,000 payable over 2 years to support junior faculty scientists in Health Policy and Public Health.
Pfizer Visiting Professorships: Up to 8 grants of $7,500 each to host medical experts in Oncology (and other therapeutic areas).
UCCC Funding Opportunities
Deadline: Dec. 1, 5 pm
More Information
ACS IRG Awards: Grants designed to entice young faculty to pursue cancer-related research problems. Funding: $180,000 total funding for 2009, $30,000 maximum award for one year. Eligibility: Instructor or Assistant Professor, U.S. citizen or permanent resident. Requires letter of committment from division/department chair. Must have no major grant support. Must be member of UCCC, or member of UC Denver or CU-Boulder faculty. Sponsored by the American Cancer Society.
In 2009, UCCC will award approximately $100,000 in grants as follows:
UCCC Seed Grants: Grants to support innovative pilot projects that have not received any prior funding. Proposals for novel clinical projects and for community-based projects are particularly encouraged. Funding: Approximately $100,000 total for 2009. $20,000 maximum, one-year award. Eligibility: UCCC member, independent junior faculty, or junior or senior faculty with innovative pilot (new research direction).
UCCC Collaborative Translational Pilot Grant: Award to emphasize the importance of multidisciplinary and interdisciplinary collaborations. Funding: $50,000 maximum for one year. Eligibility: At least two UCCC members, preferably a clinical and a basic scientist. Must be translational research project.
UCCC Research Fellowships: Matching funds to support fellow's salary and/or other research expenses. $10,000 maximum one-year award. Eligibility: Postdoctoral trainee (PhD or MD) of UCCC members. Fellowships are designed to provide matching funds for postdoctoral trainees (either PhD or MD) of UCCC members. Awards up to $10,000 will be made to support the UCCC fellow. Funds may be used for the fellow’s salary and/or other expenses related to the fellow’s research. Applications for these funds must be prepared by the fellow.
UCCC Special Emphasis Awards/Aging & Cancer: In 2009, UCCC will award approximately $150,000 on research projects in aging and cancer through its Aging and Cancer Program Grant (P20 CA103680). Proposals ranging from basic science studies of the processes related to aging that predispose the aged to cancer, to clinical studies relating factors in geriatrics to cancer screening, treatment, and outcomes are encouraged.
- Applicants should emphasize in their proposal how their study relates to aging and cancer in order to be eligible for special consideration for these funds. Both junior and senior investigators are urged to apply. Established investigators should consider how additional pilot funds from this source might extend their research into hypotheses relating aging to cancer.
- Aging and cancer pilot awards may be for $10,000 (fellowship), $20,000 (seed grant) or $50,000 (collaborative translational grant). Awards will be made for one year. Although projects will be funded for one year, applicants may indicate how a second year of funding would be used.
Week of Sept. 30
National Cancer InstituteExploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)
(PA-08-267)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
http://grants.nih.gov/grants/guide/pa-files/PA-08-267.html
2009 AACR Scientific Achievement Awards Nominations
Nomination Submission: awards@aacr.org
The AACR recognizes cancer research achievements through an array of prestigious and distinguished scientific awards. We are actively seeking nominations for awards honoring achievements in basic, clinical and translational research, epidemiology and prevention and accomplishments of young investigators, women and minorities.
By nominating a colleague today you can honor their significant contributions and potentially shape the scientific content of the 2009 Annual Meeting.
The recipients of each Award will present a major lecture during the 2009 AACR Annual Meeting, scheduled to be held on April 18-22, 2009 in Denver, CO.
We invite you to nominate a deserving candidate. We also ask you to contact your colleagues in cancer research and encourage them to nominate outstanding scientists for these awards.
For more information please AACR Awards.
Week of Sept. 16
CBSA HB-1001 Proof-of-Concept Grants and Early-Stage Company Grants
See below for links and grant deadlines
The Colorado Bioscience Association will host several educational seminars within the next 30 days to familiarize Colorado bioscience companies with the application process and rules.
The Bioscience Discovery Evaluation Grant Program was created by the Colorado legislature to foster development of the industry in Colorado, supporting both new business development and quality jobs for Coloradans. Grants have been available to develop technologies coming out of Colorado 's non-profit, research institutions over the last two years. In 2008, the program continues to support technology transfer at qualified research institutions, but now grants can be made directly to companies developing these new technologies. Strategic funds are also supporting the development of new infrastructure that will support Colorado 's growing bioscience industry.
Proof Of Concept Rules & Application
The Early-Stage Bioscience Company grants under the Bioscience Discovery Evaluation Grant Program are intended to spur economic development and help new companies born out of Colorado research institutions to succeed in developing new technologies, business structures, and product development. Grants up to $250,000 will be accessible to qualified Early-Stage Companies whose technology is licensed from a qualified Research Institution. Grants will support the commercialization of therapeutic or diagnostic products, devices, or instruments to improve human health; bioscience technologies that improve agriculture; or biofuels.
Applications for first grant cycle must be received by OEDIT on November 30, 2008.
Early-Stage Company Grants
Early-Stage Company Rules & Application
The following forms may need to be reviewed or completed by applicants for the bioscience Early-Stage Company or Proof of Concept grants.
Insurance Requirements
Credit Check Form
W-9 Form
Week of Aug. 26
American Society for Mass Spectrometry
Deadline: November 30
More information
ASMS sponsors the following prestigious awards:
- The Award for a Distinguished Contribution in Mass Spectrometry. This award recognizes a focused, singular achievement in or contribution to fundamental or applied mass spectrometry, in contrast to awards that recognize lifetime achievement. The person nominated should have made a contribution that has had a significant impact on the fundamental understanding and/or practice of mass spectrometry. Eligibility is not restricted to members of ASMS. The award is announced at the ASMS Annual Conference with the presentation of a $10,000 cash award and a recognition plaque.
- The Biemann Medal recognizes a significant achievement in basic or applied mass spectrometry made by an individual early in his or her career. Nominees should be within 15 years of receipt of the Ph.D. at the time they are nominated. The award is presented in honor of Professor Klaus Biemann whose lasting legacy is the training of students and postdoctoral associates over a 40-year period at the Massachusetts Institute of Technology. The Biemann Medal is endowed by contributions from students, postdoctoral associates and friends of Professor Biemann. Eligibility is not restricted to members of ASMS. The award is conferred at the ASMS Annual Conference with the presentation of the Biemann Medal and a cash award of $5,000.
- Research Awards in the amount of $25,000 each are presented annually. Two awards are fully sponsored by ThermoElectron Corp. and Waters Corp. The Research Awards were originated by Robert Finnigan in 1986. The purpose of the awards is to promote academic research by young scientists in mass spectrometry.
Call for Abstracts: The Keystone Symposia
Abstracts/posters represent an excellent opportunity to present your research and possibly be selected for a short talk. Submit an abstract now for:
Emerging Tumor Suppressors (B1)*
Jan. 25-30, 2009
Sagebrush Inn and Conference Center , Taos, New Mexico, U.S.A.
Organizers: Kun-Liang Guan, Eric R. Fearon and Stephen H. Friend
Abstract & Scholarship Deadline: Sep. 25, 2008
Early Registration Deadline: Nov. 25, 2008
Please visit www.keystonesymposia.org to view all meetings in our 2008-2009 series.